Inspire Medical Systems Inc (INSP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inspire Medical Systems Inc (INSP) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($12.85 Million) by net assets ($792.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Inspire Medical Systems Inc (INSP) net asset quality to measure how much of total assets are equity-financed.
Inspire Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Inspire Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Inspire Medical Systems Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Inspire Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inspire Medical Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ouster, Inc. Common Stock
NASDAQ:OUST
|
-0.059x |
|
EmbedWay Tech(Shanghai)Corp
SHG:603496
|
0.038x |
|
Deluxe Corporation
NYSE:DLX
|
0.076x |
|
ICF International Inc
NASDAQ:ICFI
|
-0.003x |
|
Lapidoth
TA:LAPD
|
0.028x |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
0.180x |
|
ITMAX System Berhad
KLSE:5309
|
-0.009x |
|
Anhui Hwasu Co.Ltd.
SHG:600935
|
N/A |
Annual Cash Flow Conversion Efficiency for Inspire Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Inspire Medical Systems Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Inspire Medical Systems Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $781.16 Million | $116.98 Million | 0.150x | -20.70% |
| 2024-12-31 | $689.70 Million | $130.25 Million | 0.189x | +338.55% |
| 2023-12-31 | $572.51 Million | $24.65 Million | 0.043x | +84.62% |
| 2022-12-31 | $496.01 Million | $11.57 Million | 0.023x | +126.55% |
| 2021-12-31 | $229.05 Million | $-20.12 Million | -0.088x | +61.96% |
| 2020-12-31 | $229.75 Million | $-53.05 Million | -0.231x | +3.27% |
| 2019-12-31 | $139.84 Million | $-33.38 Million | -0.239x | -109.40% |
| 2018-12-31 | $164.00 Million | $-18.69 Million | -0.114x | +98.93% |
| 2017-12-31 | $1.48 Million | $-15.79 Million | -10.641x | -491.75% |
| 2016-12-31 | $-6.61 Million | $-17.95 Million | 2.716x | -- |
About Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develop… Read more